Biosensors & POCT– category –
-
Biosensors & POCT
Professor Rakesh Kumar Sharma’s Team Unveils Latest Advancements in Functionalized Nanomaterials-Based Biosensing for Food and Waterborne Pathogen Monitoring
Environmental Nanotechnology, Monitoring & Management India Overview Professor Rakesh Kumar Sharma's research team has published a significant journal article detailing the latest advancements in functionalized nanomaterials-based biosen... -
Biosensors & POCT
Non-Invasive Blood Sugar Monitoring Faces Accuracy and Reliability Hurdles; True Non-Invasive Devices Remain Undeveloped
Health.com USA Overview While non-invasive blood sugar meters hold promise for finger-prick-free glucose checks, most currently available devices fail to meet the expected medical-grade accuracy and reliability for daily tracking. Many p... -
Biosensors & POCT
Waseda University Pioneers Wearable Sensors for Viral Detection and Neurotransmitter Monitoring
早稲田大学 Japan Overview Researchers at Waseda University, led by Associate Professor Jun Kameoka, have developed innovative wearable sensor technologies with significant implications for medical diagnostics. Their advancements include ... -
Biosensors & POCT
An-Najah University Engineers Unveil Ultrasensitive SPR Sensor for Antibiotic Detection in Food
An-Najah journals パレスチナ Overview Researchers at An-Najah National University have developed a novel surface plasmon resonance (SPR) sensor, enhanced with photopolymerized molecularly imprinted polymers (MIPs), for the ultrasensitive... -
Biosensors & POCT
Dorsey & Whitney Trust CO LLC Sells Abbott Laboratories Shares Amidst Focus on Libre Duo CE Mark Approval
MarketBeat USA Overview Dorsey & Whitney Trust CO LLC has reduced its holdings in Abbott Laboratories shares. Despite this divestment, Abbott is gaining significant attention for its recent CE Mark approval of Libre Duo, an innovativ... -
Biosensors & POCT
Erste Group Bank Adjusts Abbott’s FY2027 Earnings Outlook Downward, Highlights Libre Duo CE Mark as Key Growth Driver
MarketBeat USA Overview Erste Group Bank has slightly lowered its fiscal year 2027 earnings outlook for Abbott Laboratories, yet emphasizes Abbott's recent CE Mark approval for its innovative Libre Duo dual glucose-ketone sensing technol... -
Biosensors & POCT
Cambridge University & GlitterinTech Develop $10 Spectrometer Chip Delivering Lab-Grade Chemical Analysis for Non-Invasive Wearable Biomarker Monitoring
Rasayanika UK Overview Researchers from Cambridge University and GlitterinTech have developed a compact spectrometer chip costing approximately $10, capable of lab-grade chemical analysis. This centimeter-scale chip holds the potential f... -
Biosensors & POCT
UNSW Researchers Develop Tiny Wearable Auscultation Sensor for Home Monitoring of Cardiac and Respiratory Conditions
Quicknews Australia Overview Researchers at UNSW have developed a small, flexible wearable auscultation sensor designed to enable continuous home monitoring for individuals with cardiac and respiratory conditions. This sensor patch effic... -
Biosensors & POCT
Diabetes Devices Dominate FDA MAUDE Reports 2020-2025 with Over 50% of Adverse Events, Dexcom Largest Single Reporter
Global MedTech Expert | 10× MedTech Global Access Unknown Overview An analysis of 14.4 million FDA MAUDE adverse event reports from 2020 to 2025 reveals that diabetes-related devices account for over half of all reported events. Continuo... -
Biosensors & POCT
Supply Chain Integrity Under Fire: Pharmsource Denies Knowledge of Stolen, Recalled Dexcom G7 Sensors
Investing.com 南アフリカ Overview Pharmaceutical wholesaler Pharmsource LLC denies knowing that Dexcom G7 continuous glucose monitoring (CGM) sensors it acquired were stolen post-disposal and resold, despite being originally slated for d...